Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade

To analyze long-term outcomes after treatment discontinuation of anti-programmed death-1 (anti-PD-1) therapy in a cohort of patients with melanoma with the longest follow-up yet available to our knowledge, including a majority of patients treated outside of a clinical trial. We also assessed efficac...

Full description

Bibliographic Details

Published in:	Journal of clinical oncology Vol. 38; no. 15; p. 1655
Main Authors:	Betof Warner, Allison, Palmer, Jessica S, Shoushtari, Alexander N, Goldman, Debra A, Panageas, Katherine S, Hayes, Sara A, Bajwa, Raazi, Momtaz, Parisa, Callahan, Margaret K, Wolchok, Jedd D, Postow, Michael A, Chapman, Paul B
Format:	Journal Article
Language:	English
Published:	United States 20.05.2020
Subjects:	Adolescent Adult Aged Aged, 80 and over Disease Progression Female Humans Male Melanoma - drug therapy Melanoma - pathology Middle Aged Programmed Cell Death 1 Receptor - antagonists & inhibitors Retreatment - methods Retrospective Studies Young Adult
ISSN:	1527-7755, 1527-7755
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!